A randomized, multicentre, double blind, placebo controlled study of anti TNF ALPHA (ADALIMUMAB) in refractory hand osteoarthritis - Vigipallia

0 avis

A randomized, multicentre, double blind, placebo controlled study of anti TNF ALPHA (ADALIMUMAB) in refractory hand osteoarthritis

Archive ouverte

Richette, P. | Maheu, E. | Baron, G. | Ravaud, P. | Rialland, A. | Vergnaud, P. | Roux, Clément | Maugars, Y. | Mulleman, D. | Lukas, C. | Wendling, D. | Laforgue, P. | Loeuille, Damien | Foltz, V. | Chevalier, X.

Edité par CCSD -

International audience

Langue: en

Indexation

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

A randomized, multicentre, double blind, placebo-controlled trial of anti TNF alpha (adalimumab) in refractory hand osteoarthritis. The Dora study

Archive ouverte | Chevalier, X. | CCSD

Résumé. International audience

Effect of hyaluronic acid in symptomatic hip osteoarthritis : a multicentre, randomised, double-blind, placebo-controlled study.

Archive ouverte | Richette, P. | CCSD

International audience

EFFECTS OF INTRA-ARTICULAR INJECTIONS OF HYLAN GF-20 ON SERUM AND URINE BIOMARKERS IN PATIENTS WITH KNEE OSTEOARTHRITIS: THE BIOVISCO STUDY

Archive ouverte | Conrozier, T. | CCSD

International audience

Chargement des enrichissements...